  Sepsis<disease> is a serious life threatening medical emergency which , if not treated properly , oftentimes results in organ<symptom> failure<symptom> and death. Current sepsis<disease> treatment protocols are largely centered on the use of antibiotics and supportive care. Recent studies have suggested that antibiotics fail to be effective for sepsis<disease> treatment when administered during hypo-dynamic phase of sepsis<disease> that is usually characterized by the presence of a cytokine storm. As such , there is an urgent need to develop novel therapeutic drugs that target the inflammatory cytokines that are secreted as a result of increased reactive oxygen species. Cerium oxide nanoparticles ( CeO